2 hours ago
Eli Lilly (LLY) Stock Climbs on Foundayo Trial Results Showing 57% Reduction in Death Risk
Eli Lilly (LLY) stock rises as Foundayo obesity pill shows 57% lower death risk and 16% reduction in heart attacks. FDA approval expected Q2 2026.
The post Eli Lilly (LLY) Stock Climbs on Foundayo Trial Results Showing 57% Reduction in Death Risk appeared first on Blockonomi.
Source: Blockonomi →Related News
- 46 minutes ago
Navitas Semiconductor (NVTS) Surges 15% as Former Broadcom Executive Joins Board
- 2 hours ago
Rocket Lab (RKLB) Stock Climbs 10% Following Mynaric Closure and Gauss Thruster...
- 2 hours ago
AMD Stock Surges to Record High With Unprecedented 12-Day Rally
- 2 hours ago
Ciena (CIEN) Stock Jumps as Analysts Set $550 Price Target on AI Networking Boom
- 3 hours ago
Wolfe Research Highlights Meta (META), Uber (UBER), DoorDash (DASH), and Shopify...